An overview of mouse models of hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) has become a severe burden on global health due to its high morbidity and mortality rates. However, effective treatments for HCC are limited. The lack of suitable preclinical models may contribute to a major failure of drug development for HCC. Here, we overvi...
Main Authors: | Hua-chuan Zheng, Hang Xue, Wen-Jing Yun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Infectious Agents and Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13027-023-00524-9 |
Similar Items
-
Mouse Models for Immunotherapy in Hepatocellular Carcinoma
by: Enya Li, et al.
Published: (2019-11-01) -
Advances in experimental animal models of hepatocellular carcinoma
by: Jing Li, et al.
Published: (2023-07-01) -
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
by: Yen-Hao Chen, et al.
Published: (2023-08-01) -
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
by: Cedric Brackenier, et al.
Published: (2023-01-01) -
Establishment of image‐guided radiotherapy of orthotopic hepatocellular carcinoma mouse model
by: Kaixiao Zhou, et al.
Published: (2023-10-01)